Caribou Biosciences, Inc. Common Stock

CRBU Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership

Chart provided by TradingView

Income
Balance Sheet
Cash Flow
CRBU Income Statement
CRBU Balance Sheet
CRBU Cash Flow
Congress Trading

Recent trades of CRBU by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
CRBU Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
CRBU Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
CRBU Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by CRBU's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard
Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
Corporate Lobbying

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Modified cascade ribonucleoproteins and uses thereof Mar. 26, 2024
  • Patent Title: Engineered cascade components and cascade complexes Jan. 17, 2023
  • Patent Title: Engineered nucleic acid-targeting nucleic acids Nov. 22, 2022
  • Patent Title: Humanized bcma antibody and bcma-car-t cells Oct. 18, 2022
  • Patent Title: Methods of use of crispr cpf1 hybrid dna/rna polynucleotides Oct. 04, 2022
  • Patent Title: Compositions and methods of nucleic acid-targeting nucleic acids Apr. 26, 2022
  • Patent Title: Humanized bcma antibody and bcma-car-t cells Apr. 12, 2022
  • Patent Title: Crispr hybrid dna/rna polynucleotides and methods of use Feb. 01, 2022
  • Patent Title: Engineered nucleic-acid targeting nucleic acids Jan. 18, 2022
  • Patent Title: Methods for using dna repair for cell engineering Oct. 26, 2021
  • Patent Title: Bcma-car-natural killer (nk) cells and methods related thereto Oct. 12, 2021
  • Patent Title: Compositions and methods of engineered crispr-cas9 systems using split-nexus cas9-associated polynucleotides Sep. 07, 2021
  • Patent Title: Humanized bcma antibody and bcma-car-t cells Jun. 01, 2021
  • Patent Title: Engineered nucleic acid-targeting nucleic acids May. 11, 2021
  • Patent Title: Method of target cleaving using crispr hybrid dna/rna polynucleotides Apr. 27, 2021
  • Patent Title: Modified cascade ribonucleoproteins and uses thereof Mar. 23, 2021
  • Patent Title: Humanized bcma antibody and bcma-car-t cells Feb. 23, 2021
  • Patent Title: Engineered cascade components and cascade complexes Sep. 22, 2020
  • Patent Title: Engineered nucleic-acid targeting nucleic acids Jul. 14, 2020
  • Patent Title: Modified cascade ribonucleoproteins and uses thereof Jul. 14, 2020
  • Patent Title: Engineered nucleic-acid targeting nucleic acids Dec. 10, 2019
  • Patent Title: Engineered cascade components and cascade complexes Oct. 29, 2019
  • Patent Title: Modified cascade ribonucleoproteins and uses thereof Oct. 08, 2019
  • Patent Title: Engineered cascade components and cascade complexes Jun. 25, 2019
  • Patent Title: Engineered cascade components and cascade complexes Mar. 12, 2019
  • Patent Title: Engineered nucleic-acid targeting nucleic acids Feb. 05, 2019
  • Patent Title: Engineered nucleic-acid targeting nucleic acids Nov. 27, 2018
  • Patent Title: Methods of modifying a target nucleic acid with an argonaute Nov. 13, 2018
  • Patent Title: Compositions and methods of nucleic acid-targeting nucleic acids Nov. 13, 2018
  • Patent Title: Engineered nucleic-acid targeting nucleic acids Nov. 13, 2018
  • Patent Title: Engineered nucleic acid-targeting nucleic acids Oct. 16, 2018
  • Patent Title: Engineered nucleic-acid targeting nucleic acids Jul. 17, 2018
  • Patent Title: Methods for increasing cas9-mediated engineering efficiency May. 15, 2018
  • Patent Title: Engineered nucleic acid-targeting nucleic acids May. 15, 2018
  • Patent Title: Compositions and methods of engineered crispr-cas9 systems using split-nexus cas9-associated polynucleotides May. 15, 2018
  • Patent Title: Compositions and methods of engineered crispr-cas9 systems using split-nexus cas9-associated polynucleotides May. 15, 2018
  • Patent Title: Cells comprising engineered nucleic-acid targeting nucleic acids May. 01, 2018
  • Patent Title: Compositions and methods of nucleic acid-targeting nucleic acids Mar. 06, 2018
  • Patent Title: Methods of modifying a target nucleic acid with an argonaute Feb. 27, 2018
  • Patent Title: Modified cascade ribonucleoproteins and uses thereof Feb. 06, 2018
  • Patent Title: Engineered nucleic acid-targeting nucleic acids Nov. 14, 2017
  • Patent Title: Engineered nucleic-acid targeting nucleic acids Nov. 14, 2017
  • Patent Title: Compositions and methods of nucleic acid-targeting nucleic acids Nov. 07, 2017
  • Patent Title: Compositions and methods of nucleic acid-targeting nucleic acids Oct. 31, 2017
  • Patent Title: Engineered nucleic acid-targeting nucleic acids Sep. 26, 2017
  • Patent Title: Compositions and methods of engineered crispr-cas9 systems using split-nexus cas9-associated polynucleotides Aug. 29, 2017
  • Patent Title: Methods of using engineered nucleic-acid targeting nucleic acids Aug. 29, 2017
  • Patent Title: Compositions and methods of nucleic acid-targeting nucleic acids Aug. 08, 2017
  • Patent Title: Engineered nucleic-acid targeting nucleic acids Jun. 13, 2017
  • Patent Title: Compositions and methods of engineered crispr-cas9 systems using split-nexus cas9-associated polynucleotides Feb. 28, 2017
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of CRBU in WallStreetBets Daily Discussion

CRBU News

Recent insights relating to CRBU

CNBC Recommendations

Recent picks made for CRBU stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in CRBU

CRBU Top Shareholders
Shareholder
Shares Held
CRBU Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

CRBU Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view CRBU Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top